Tag: featured story

Leaders from the University of Rochester and University of Rochester Medical Center, government officials, and community supporters gathered to celebrate the University’s largest capital project in ...

A smartphone app that detects signs of tooth decay developed by University of Rochester scientists is one step closer to reality, thanks to a grant from the National Science Foundation.

The FDA has approved valbenazine as a treatment for Huntington’s disease chorea. A team of URMC researcher provided scientific, technical, logistical, and operational support for the phase 3 study ...

The new recommendations are guided by the belief that parents know their children best and that children have a plethora of interests (including, but not limited to medical) that influence their ...

White coats were presented to the University of Rochester School of Medicine and Dentistry Class of 2027 during the traditional ceremony that marks the beginning of medical school for these future ...

The odds of surviving sudden cardiac arrest can double when someone quickly receives cardiopulmonary resuscitation (CPR.) UR Medicine leaders, in collaboration with the American Heart Association, ...

Understanding the role of chronic pain in the brain could transform treatment and care for a condition that inflicts more than 20 percent of US adults. An associate professor of Psychiatry at URMC ...

Black patients with implantable cardioverter defibrillators have a higher burden of disease than white patients with the same device, according to new URMC cardiology research.

Thirty different countries were represented among the Eastman Institute for Oral Health’s 77 graduates who crossed the stage Friday evening at a ceremony held in the University’s Feldman Ballroom.

Emma Ciafaloni, MD, describes how the new drug works, why the FDA chose to limit its use, and what it means for patients and their families.